Related Experiment Video

Updated: Aug 30, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

514

Hospitalizations for Cardiovascular Diseases During the Early Stage of the COVID-19 Pandemic in Japan

Tadafumi Sugimoto1,2, Atsushi Mizuno2,3,4,5, Daisuke Yoneoka6

  • 1Department of Cardiology and Nephrology, Mie University Graduate School of Medicine Tsu Japan.

Circulation Reports
|August 29, 2022
PubMed

Insights

The COVID-19 pandemic led to fewer hospitalizations for cardiovascular disease (CVD) treatment in Japan. This decrease in cardiovascular disease hospitalizations occurred even during the pandemic's early stages.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Reductions in hospitalizations for myocardial infarction and heart failure during COVID-19 restrictions were noted.
  • The overall impact on cardiovascular disease (CVD) treatment hospitalizations in early pandemic stages remained unclear.

Purpose of the Study:

  • To analyze changes in the overall number of hospitalizations for cardiovascular disease (CVD) treatment during the early COVID-19 pandemic.
  • To assess the association between COVID-19 spread and CVD hospitalizations in Japan.

Main Methods:

  • Utilized data from 574 hospitals in the Japanese Registry of All Cardiac and Vascular Diseases-Diagnosis Procedure Combination database (April 2015-March 2020).
  • Employed a quasi-Poisson regression model to estimate hospitalization numbers for CVD treatment.
  • Analyzed actual versus estimated hospitalizations for acute and scheduled CVD treatments between January and March 2020.

Main Results:

  • Hospitalizations for acute CVD were 84.3% of estimated values, and scheduled hospitalizations were 88.7%.
  • Specific conditions like acute heart failure (81.1%), scheduled valvular disease (84.6%), and aortic aneurysm (83.8%) showed decreased hospitalizations.
  • Results remained consistent even when analyzing facilities without hospitalization restrictions.

Conclusions:

  • The spread of COVID-19 was associated with a significant decrease in cardiovascular disease hospitalizations in Japan.
  • This reduction in CVD treatment admissions was evident even in the initial phases of the pandemic.

Keywords:
COVID-19Cardiovascular diseaseHospitalizationsJapanese Registry of All Cardiac and Vascular Diseases–Diagnosis Procedure Combination (JROAD-DPC)

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.6K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.6K

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
47
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
26
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
29
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
33
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
60